New hope for advanced tumors? first human trial of SIM0505 begins
Disease control
Recruiting now
This early-stage study tests a new drug, SIM0505, in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. About 414 people will take part across multiple c…
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Apr 29, 2026 04:27 UTC